HIV treatment as prevention: natural experiments highlight limits of antiretroviral treatment as HIV prevention.
about
HIV treatment as prevention: contradictory perspectives from dynamic mathematical modelsPharmaceutical HIV prevention technologies in the UK: six domains for social science researchEconomic recession and emergence of an HIV-1 outbreak among drug injectors in Athens metropolitan area: a longitudinal studySources of HIV infection among men having sex with men and implications for preventionFrench HIV experts on early antiretroviral treatment for prevention: uncertainty and heterogeneity.Personalized Biobehavioral HIV Prevention for Women and Adolescent Girls.Strong propensity for HIV transmission among men who have sex with men in Vietnam: behavioural data and sexual network modelling.Many hepatitis C reinfections that spontaneously clear may be undetected: Markov-chain Monte Carlo analysis of observational study data.Global HIV epidemiology: A guide for strategies in prevention and care.Biomedical prevention: state of the science.Decrease in sexual risk behaviours after early initiation of antiretroviral therapy: a 24-month prospective study in Côte d'Ivoire.Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models.Antiretroviral therapy uptake, attrition, adherence and outcomes among HIV-infected female sex workers: a systematic review and meta-analysis.HIV treatment as prevention: systematic comparison of mathematical models of the potential impact of antiretroviral therapy on HIV incidence in South AfricaHIV treatment as prevention: modelling the cost of antiretroviral treatment--state of the art and future directions.HIV treatment as prevention: models, data, and questions--towards evidence-based decision-making.Antiretroviral treatment of HIV-1 prevents transmission of HIV-1: where do we go from here?The impact of the 2013 WHO antiretroviral therapy guidelines on the feasibility of HIV population prevention trials.Ten year trends in community HIV viral load in Barbados: implications for treatment as prevention.An intersectionality-based policy analysis framework: critical reflections on a methodology for advancing equity.Modeling the implementation of universal coverage for HIV treatment as prevention and its impact on the HIV epidemic.Measuring HIV stigma at the family level: psychometric assessment of the Chinese Courtesy Stigma Scales (CCSSs).Gay and bisexual men's awareness and knowledge of treatment as prevention: findings from the Momentum Health Study in Vancouver, Canada.A longitudinal cohort study of HIV 'treatment as prevention' in gay, bisexual and other men who have sex with men: the Treatment with Antiretrovirals and their Impact on Positive And Negative men (TAIPAN) study protocol.The HIV care cascade: Japanese perspectivesEthical use of antiretroviral resources for HIV prevention in resource poor settings.Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial.Changing Antiretroviral Eligibility Criteria: Impact on the Number and Proportion of Adults Requiring Treatment in SwazilandFactors Influencing Access and Use of Care and Treatment Services among Iranian People Living with HIV and AIDS: A Qualitative Study.Test-and-treat in Los Angeles: a mathematical model of the effects of test-and-treat for the population of men who have sex with men in Los Angeles County.Provision of rapid HIV tests within a health service and frequency of HIV testing among men who have sex with men: randomised controlled trial.High retention in care among HIV-infected patients entering care with CD4 levels >350 cells/μL under routine program conditions in Uganda.Men, masculinity, and engagement with treatment as prevention in KwaZulu-Natal, South Africa.Effect of early antiretroviral therapy on sexual behaviors and HIV-1 transmission risk among adults with diverse heterosexual partnership statuses in Côte d'Ivoire.Impact of Antiretroviral Therapy on the Spread of Human Immunodeficiency Virus in Chaoyang District, Beijing, China: Using the Asian Epidemic Model.Determinants of viremia copy-years in people with HIV/AIDS after initiation of antiretroviral therapy.Antiretroviral therapy for prevention is a combination strategy.Who pays and why? Costs, effectiveness, and feasibility of HIV treatment as prevention.Programmatic and ethical challenges in the implementation of treatment-as-prevention in the context of HIV and drug-resistant tuberculosis co-infection in sub-Saharan Africa.The effect of prevention methods on reducing sexual risk for HIV and their potential impact on a large-scale: a literature review.
P2860
Q28080917-AC0022B4-4243-49D0-8884-B585C317E6ADQ28081560-601FD5E7-1727-4CA4-8B3C-904D29192DB0Q28535029-E7B24A29-1CF9-45B8-9A55-1CA9280AE9D6Q28601386-5753CA40-C88B-4F7B-8244-E9056DF3BFE0Q30222819-68AA2B5C-B5F5-4459-B076-32D74457300DQ30357818-4338B5AA-CF29-4445-9FD1-10663546B6A1Q30735928-C5F59687-1528-4F68-9F3A-E6F5208D733DQ30884457-EE999FAA-7AD7-4C9E-8A16-ED7544D28C2CQ33703135-F3BC0952-9476-43DE-9FC7-35DB6D8E9DAFQ33765795-BD54EA8B-D055-4707-AD28-3D254C676B2DQ33832234-16ECE2DA-23F4-4625-9080-A1E63A281C10Q33966505-5F4A6178-36FF-4142-BADE-4C72BA9334B0Q34263816-88A45D24-08B9-4526-9221-CDA898347240Q34339465-36CAAB11-C9C7-4FBD-84F4-1F3565EEE8EFQ34339471-3D469E87-B111-4E89-943A-FA6D1C698F36Q34339523-17F488EB-51D3-4DC2-A0BF-E267BEB8CD3AQ34379806-1D7BD3D7-1648-495E-B5EA-F7DB4131987FQ34418077-0392999D-0DED-4333-B05D-CC3418F4A7C1Q34631863-C740FA47-5174-49FE-B29A-847DD75ECAD2Q34740076-3514F6F0-39CD-4980-B5BB-C0E170661885Q34993280-67DA2150-8D4C-4E72-89CB-2EA43A1828A9Q35128185-0ED656B4-B8DD-4F8C-AAE2-F69CDEE3EB9CQ35947588-18B9EF0C-2D4D-4D12-B6DB-6E58186219F2Q36220750-A379DC9C-35C7-47D1-BD27-3532E4A9E078Q36314922-E8AB927E-1F00-4ACA-A665-E4DD73BB9792Q36377733-8E66AF85-E3DB-49F7-9C60-0F78B08B1CF0Q36426896-B4A01B9F-89A9-44D4-84F1-EBE56709F1FAQ36576582-9370B530-6D16-4BE7-9D31-1CDB27CE4290Q36769748-763F0693-12B1-48EB-A8A8-ADF28A450110Q36856942-7AAE67FD-098B-43F5-9676-F22574852A0EQ37145865-4E50FB68-C6CB-4804-A018-57121E130BEBQ37220792-5C81A49E-25F1-44B4-8C37-8CC6F2A47AF1Q37395460-21A00CBA-AFEB-4C1C-B74D-1892FE96D3E0Q37443074-1AF7A5B1-EB9A-4F5F-A229-752300BF2176Q37572404-F4543EC4-6F3A-47D9-88EA-83ED6D8DEAA6Q37695051-0F823603-94DD-4602-9BF8-CE194234C8BCQ38078278-53778420-C4FB-44DA-B76D-0071CF8DD87FQ38219957-2A42455F-E5D6-4F83-81C7-6C5097E17762Q38393167-7233122C-DE16-4AD1-B455-921435EE1685Q38656815-2F238433-09EE-42C2-94B8-BE64F0C1B634
P2860
HIV treatment as prevention: natural experiments highlight limits of antiretroviral treatment as HIV prevention.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
HIV treatment as prevention: n ...... l treatment as HIV prevention.
@ast
HIV treatment as prevention: n ...... l treatment as HIV prevention.
@en
HIV treatment as prevention: n ...... l treatment as HIV prevention.
@nl
type
label
HIV treatment as prevention: n ...... l treatment as HIV prevention.
@ast
HIV treatment as prevention: n ...... l treatment as HIV prevention.
@en
HIV treatment as prevention: n ...... l treatment as HIV prevention.
@nl
prefLabel
HIV treatment as prevention: n ...... l treatment as HIV prevention.
@ast
HIV treatment as prevention: n ...... l treatment as HIV prevention.
@en
HIV treatment as prevention: n ...... l treatment as HIV prevention.
@nl
P2860
P921
P1433
P1476
HIV treatment as prevention: n ...... l treatment as HIV prevention.
@en
P2093
David P Wilson
P2860
P304
P356
10.1371/JOURNAL.PMED.1001231
P407
P5008
P577
2012-07-10T00:00:00Z